News · 26 weeks36-100%
2026-03-012026-08-23
Mix2190d
- SEC Filings12(57%)
- Other9(43%)
Latest news
25 items- SECSEC Form 15-12G filed by Vicarious Surgical Inc.15-12G - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form EFFECT filed by Vicarious Surgical Inc.EFFECT - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form POS AM filed by Vicarious Surgical Inc.POS AM - Vicarious Surgical Inc. (0001812173) (Filer)
- SECVicarious Surgical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - Vicarious Surgical Inc. (0001812173) (Filer)
- SECVicarious Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form DEF 14A filed by Vicarious Surgical Inc.DEF 14A - Vicarious Surgical Inc. (0001812173) (Filer)
- SECSEC Form PRE 14A filed by Vicarious Surgical Inc.PRE 14A - Vicarious Surgical Inc. (0001812173) (Filer)
- PRVicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical SettingWALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB:RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the "Company"), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System. During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted us
- SECSEC Form 10-Q filed by Vicarious Surgical Inc.10-Q - Vicarious Surgical Inc. (0001812173) (Filer)
- PRVicarious Surgical Reports First Quarter 2026 Financial ResultsWALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (OTCQB:RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Results Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%. Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million in the first quarter of 2025, a decrease of 46%. General and administrative expenses in the
- SECVicarious Surgical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Vicarious Surgical Inc. (0001812173) (Filer)
RBOT FAQ
7 questionsWhat does Vicarious Surgical Inc. do?
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Where does RBOT stock trade?
Vicarious Surgical Inc. (RBOT) is listed on NYSE.What sector and industry is RBOT in?
Vicarious Surgical Inc. operates in the Health Care sector, Industrial Specialties industry.When did Vicarious Surgical Inc. go public?
Vicarious Surgical Inc. (RBOT) completed its IPO in 2020.What are analysts saying about RBOT?
Vicarious Surgical Inc. has had 6 recent analyst actions on file. The most recent action was from Piper Sandler: Neutral with a $700.00 price target on 2022-03-04. Recent price targets range from $700.00 to $1600.00.What companies are similar to RBOT?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare RBOT side-by-side with any of them on Quantisnow.How can I track RBOT on Quantisnow?
Quantisnow aggregates Vicarious Surgical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RBOT to receive live email and push alerts on every new disclosure.